R. Berger

1.4k total citations
44 papers, 1.1k citations indexed

About

R. Berger is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, R. Berger has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 11 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in R. Berger's work include Virology and Viral Diseases (8 papers), Herpesvirus Infections and Treatments (8 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). R. Berger is often cited by papers focused on Virology and Viral Diseases (8 papers), Herpesvirus Infections and Treatments (8 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). R. Berger collaborates with scholars based in Switzerland, France and Germany. R. Berger's co-authors include M Just, G. Florent, Reinhard Glück, Emanuelle Trannoy, Fabrice Bailleux, Georg A. Holländer, E Signer, H Gaze, N. Scheiermann and H. Huber and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and The Journal of Infectious Diseases.

In The Last Decade

R. Berger

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Berger Switzerland 20 748 213 161 160 140 44 1.1k
M Just Switzerland 24 1.0k 1.4× 356 1.7× 349 2.2× 142 0.9× 197 1.4× 86 1.7k
Allan M. Arbeter United States 21 736 1.0× 150 0.7× 139 0.9× 115 0.7× 51 0.4× 39 936
A. W. Gledhill Tanzania 17 358 0.5× 216 1.0× 100 0.6× 62 0.4× 41 0.3× 36 822
Mary B. Mazanec United States 12 435 0.6× 322 1.5× 582 3.6× 35 0.2× 27 0.2× 14 1.3k
Himal Lal Belgium 14 1.3k 1.7× 215 1.0× 189 1.2× 376 2.4× 56 0.4× 23 1.6k
J. Nagington United Kingdom 21 521 0.7× 267 1.3× 128 0.8× 60 0.4× 119 0.8× 52 1.5k
Maria Irma Seixas Duarte Brazil 25 808 1.1× 647 3.0× 276 1.7× 311 1.9× 60 0.4× 124 1.9k
Kihei Terada Japan 18 714 1.0× 109 0.5× 62 0.4× 72 0.5× 15 0.1× 57 995
Paul D. Parkman United States 21 1.6k 2.1× 607 2.8× 246 1.5× 52 0.3× 42 0.3× 51 2.0k
R. B. Heath United Kingdom 22 1.0k 1.4× 421 2.0× 290 1.8× 101 0.6× 31 0.2× 70 1.5k

Countries citing papers authored by R. Berger

Since Specialization
Citations

This map shows the geographic impact of R. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Berger more than expected).

Fields of papers citing papers by R. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Berger. The network helps show where R. Berger may publish in the future.

Co-authorship network of co-authors of R. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of R. Berger. A scholar is included among the top collaborators of R. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Berger. R. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, R.. (2011). t(3;5)(q25;q34). Atlas of Genetics and Cytogenetics in Oncology and Haematology.
2.
Berger, R., et al.. (2006). Cord Blood Screening for Congenital Toxoplasmosis in Northwestern Switzerland, 1982–1999. The Pediatric Infectious Disease Journal. 25(2). 123–128. 21 indexed citations
3.
4.
Berger, R., et al.. (1998). A Dose‐Response Study of a Live Attenuated Varicella‐Zoster Virus (Oka Strain) Vaccine Administered to Adults 55 Years of Age and Older. The Journal of Infectious Diseases. 178(s1). S99–S103. 37 indexed citations
5.
Berger, R., et al.. (1995). Virosomes as carriers for combined vaccines. Vaccine. 13(14). 1306–1315. 36 indexed citations
6.
7.
Rudin, Christoph, et al.. (1993). INTRAUTERINE ONSET OF SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS DISEASE. The Pediatric Infectious Disease Journal. 12(5). 411–413. 10 indexed citations
8.
Berger, R., M Just, & Beat Althaus. (1993). Time course of hepatitis A antibody production after active, passive and active/passive immunisation: The results are highly dependent on the antibody test system used. Journal of Virological Methods. 43(3). 287–297. 27 indexed citations
9.
10.
Just, M & R. Berger. (1992). Reactogenicity and immunogenicity of inactivated hepatitis A vaccines. Vaccine. 10. S110–S113. 17 indexed citations
11.
Rudin, Christoph, et al.. (1991). Repeated polymerase chain reaction complementary to other conventional methods for early detection of HIV infection in infants born to HIV-infected mothers. European Journal of Clinical Microbiology & Infectious Diseases. 10(3). 146–156. 9 indexed citations
12.
13.
Stürchler, D, R. Berger, H. Etlinger, et al.. (1989). Effects of interferons on immune response to a synthetic peptide malaria sporozoite vaccine in non-immune adults. Vaccine. 7(5). 457–461. 22 indexed citations
14.
Berger, R. & M Just. (1988). Interference between strains in live virus vaccines II: combined vaccination with varicella and measles-mumps-rubella vaccine. Journal of Biological Standardization. 16(4). 275–279. 24 indexed citations
15.
Just, M & R. Berger. (1988). Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine. Vaccine. 6(5). 399–400. 12 indexed citations
16.
Just, M, R. Berger, & N. Scheiermann. (1988). Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine. Vaccine. 6(5). 401–402. 15 indexed citations
17.
Berger, R., M Just, & Reinhard Glück. (1988). Interference between strains in live virus vaccines I: combined vaccination with measles, mumps and rubella vaccine. Journal of Biological Standardization. 16(4). 269–273. 18 indexed citations
18.
Just, M, R. Berger, Reinhard Glück, & A Wegmann. (1986). Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.. PubMed. 65. 25–7. 7 indexed citations
19.
Just, M, et al.. (1985). Live varicella vaccine in healthy individuals.. PubMed. 61 Suppl 4. 129–32. 23 indexed citations
20.
Berger, R., et al.. (1984). Enhancement of Varicella-Zoster-Specific Immune Responses in the Elderly by Boosting with Varicella Vaccine. The Journal of Infectious Diseases. 149(4). 647–647. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Just Breakdown of academic impact, for papers by Allan M. Arbeter Breakdown of academic impact, for papers by A. W. Gledhill Breakdown of academic impact, for papers by Mary B. Mazanec Breakdown of academic impact, for papers by Himal Lal Breakdown of academic impact, for papers by J. Nagington Breakdown of academic impact, for papers by Maria Irma Seixas Duarte Breakdown of academic impact, for papers by Kihei Terada Breakdown of academic impact, for papers by Paul D. Parkman Breakdown of academic impact, for papers by R. B. Heath
Rankless by CCL
2026